Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients.

Published: 2020-07-18

DOI: 10.1016/j.chom.2020.07.005

Affiliations: 14

Authors: 20

Institutions	Authors	Share
Suizhou Zengdu Hospital, China		0.35
The Seventh Affiliated Hospital, SYSU, China		0.24
Xiangyang Central Hospital, China		0.18
Xiangyang Central Blood Station, China		0.05
Mount Sinai St. Luke’s, MSHS, United States of America (USA)		0.05
Peking University Shenzhen Hospital, China		0.05
Department of Biomedical Sciences (BMS), CityU, China		0.03
Medical College, Hubei University of Arts and Science, China		0.03
VA NY Harbor Health Care System, United States of America (USA)		0.02
Department of Cell Biology, SUNY Downstate, United States of America (USA)		0.02

Return

Latest supplement

Nature Index 2021 Asia Pacific

Sustainability, climate-change mitigation, and biomedical science are key areas for future research prowess in the Asia-Pacific region. While COVID-19 travel restrictions have disrupted collaborations between far-flung nations, they have focused attention on vast opportunities for researchers in countries in close proximity and South and southeast Asia to work more closely together on new initiatives.

Access free